Explore Penn Medicine
Penn Medicine Home
Departments & Services
Patient Care
Healthcare Professionals
Research & Trials
Education
Find a Doctor
Search this site
Abramson Cancer Center
Make an Appointment
Donate
Clinical Trials
Referring Physicians
OncoLink
Share
|
PATIENT & CANCER INFORMATION
RESEARCH
HOME
CANCER TYPES
CANCER TREATMENT AT PENN
SUPPORT AND RESOURCES
CENTERS, PROGRAMS & CLINICAL SERVICES
ONCOLINK
PATIENTS
»
CLINICAL TRIALS
» PEDIATRIC BLOOD-RELATED CANCERS
Find a Doctor/Researcher
Make an Appointment
Refer a Patient
Make a Gift
Explore Penn Cancer Network
Learn About Us
Find a Clinical Trial
-Please Select Type of Trial-
Bladder Cancer
Brain Tumor
Breast Cancer
Cervical Cancer
Colorectal Cancer
Endometrial/Uterine Cancer
Esophageal
Gastrointestinal Stromal Tumor (GIST)
Head and Neck Cancer
Hodgkin lymphoma
Kidney Cancer
Leukemia/Myelodysplastic Syndrome
Liver Cancer
Lung Cancer
Melanoma
Multiple Myeloma
Non-Hodgkin lymphoma
Other Cancers
Ovarian Cancer
Pancreatic Cancer
Pediatric Blood-Related Cancers
Prevention & Early Detection Trials for Men
Prevention & Early Detection Trials for Women
Prostate Cancer
Sarcoma
Stomach Cancer
Testicular Cancer
Thyroid Cancer
Clinical Trials
About Clinical Trials
Clinical Trials Matching Service
Early Phase Clinical Trials - Developmental Therapeutics
How are clinical trials carried out?
Questions to Ask Your Doctor or Nurse
Special Considerations
What is a Clinical Trial?
What Sets Penn's Clinical Trials Apart?
Why are Clinical Trials Important?
Why Consider a Clinical Trial?
Clinical Trials
Pediatric Blood-Related Cancers Trials
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute GVHD (BMT CTN 0802)
A Phase III Randomized, Multicenter Trial Comparing Sirolimus/Tacrolimus With Tacrolimus/Methotrexate as Graft-Versus-Host Disease (GVHD) Prophylaxis After HLA-Matched, Related Peripheral Blood Stem Cell Transplantation (BMT CTN #0402)
An Intergroup Phase II Clinical Trial for Adolescents and Young Adults With Untreated Acute Lymphoblastic Leukemia (ALL)